Bill Alpert is a Senior Writer at Barron’s, where since 1984 he has published nerdy feature stories, columns and investigative projects of use to investors.

Joined July 2009
$GH enters the multicancer screening market next month……………………………..Guardant’s New Blood Test Can Detect Many Different Cancers. The Company Is Promising the Same for Other Diseases. - Barron's barrons.com/articles/guardan…
208
Listed penny stocks cause problems for everyone except those associated with the companies. Reverse stock splits mark some of the most problematic ones... These Companies Gain Through Reverse Stock Splits. Shareholders Often Lose Out. barrons.com/articles/reverse… via @BarronsOnline
1
1
3
326